Covid 19

COVID-19

Our efforts to help in the fight against COVID-19: In February 2020, we started our efforts to better understand COVID-19, the disease, transmission and infections in order to help and tackle the Pandemic and COVID-19.  Here are two papers by the SMDG team and collaborators based on our work, research, understanding and hypothesis on the severity of COVID-19 and transmission of the disease.   

Molecular Therapy2.jpg

Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines

This perspective article in Molecular Therapy by Professor Moein Moghimi, Newcastle University and Co-founder of SMDG provides insights as to what might be causing allergic reactions to lipid-nanoparticle based COVID-19 vaccines.

February 2021

PRNANO Vol 3(3) Cover.png

Elevated Circulating Endothelin-1 as a Potential Biomarker for High-Risk COVID-19 Severity

A hypothesis paper in Precision Nanomedicine by the SMDG team takes a detailed and extensive look at severe cases of COVID-19 and proposes a biomarker and way forward in tackling the disease.

July 2020

fimmu_2.jpg

Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting — A Hypothesis

A hypothesis paper in the Frontiers in Immunology by the SMDG team and collaborators at Newcastle University, UK, the University of Milano-Bicocca, Italy and University of Lincoln, UK, takes a detailed and extensive look at airborne transmission of coronavirus-2 and the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in humans. 

September 2020